The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Lung Cancer Surgery Market Research Report 2025

Global Lung Cancer Surgery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1904718

No of Pages : 85

Synopsis

Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma.

The global Lung Cancer Surgery market was valued at US$ 20220 million in 2023 and is anticipated to reach US$ 30200 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Surgery.

Report Scope

The Lung Cancer Surgery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Accuray
  • Angiodynamics
  • Ethicon
  • Intuitive Surgical
  • Olympus
  • Teleflex
  • Ackermann Instrumente
  • Karl Storz
  • Scanlan International
  • Trokamed

Segment by Type

  • Surgical Instruments
  • Monitoring And Visualization System

Segment by Application

  • Lobectomy
  • Removal Of Sleeve
  • Regional Excision
  • Lung Removed All
  • Minimally Invasive Surgery

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Surgery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Surgery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgical Instruments
1.2.3 Monitoring And Visualization System
1.3 Market by Application
1.3.1 Global Lung Cancer Surgery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Lobectomy
1.3.3 Removal Of Sleeve
1.3.4 Regional Excision
1.3.5 Lung Removed All
1.3.6 Minimally Invasive Surgery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Surgery Market Perspective (2019-2030)
2.2 Lung Cancer Surgery Growth Trends by Region
2.2.1 Global Lung Cancer Surgery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lung Cancer Surgery Historic Market Size by Region (2019-2024)
2.2.3 Lung Cancer Surgery Forecasted Market Size by Region (2025-2030)
2.3 Lung Cancer Surgery Market Dynamics
2.3.1 Lung Cancer Surgery Industry Trends
2.3.2 Lung Cancer Surgery Market Drivers
2.3.3 Lung Cancer Surgery Market Challenges
2.3.4 Lung Cancer Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Surgery Players by Revenue
3.1.1 Global Top Lung Cancer Surgery Players by Revenue (2019-2024)
3.1.2 Global Lung Cancer Surgery Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Surgery Revenue
3.4 Global Lung Cancer Surgery Market Concentration Ratio
3.4.1 Global Lung Cancer Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Surgery Revenue in 2023
3.5 Lung Cancer Surgery Key Players Head office and Area Served
3.6 Key Players Lung Cancer Surgery Product Solution and Service
3.7 Date of Enter into Lung Cancer Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Surgery Breakdown Data by Type
4.1 Global Lung Cancer Surgery Historic Market Size by Type (2019-2024)
4.2 Global Lung Cancer Surgery Forecasted Market Size by Type (2025-2030)
5 Lung Cancer Surgery Breakdown Data by Application
5.1 Global Lung Cancer Surgery Historic Market Size by Application (2019-2024)
5.2 Global Lung Cancer Surgery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lung Cancer Surgery Market Size (2019-2030)
6.2 North America Lung Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lung Cancer Surgery Market Size by Country (2019-2024)
6.4 North America Lung Cancer Surgery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Surgery Market Size (2019-2030)
7.2 Europe Lung Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lung Cancer Surgery Market Size by Country (2019-2024)
7.4 Europe Lung Cancer Surgery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Surgery Market Size (2019-2030)
8.2 Asia-Pacific Lung Cancer Surgery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lung Cancer Surgery Market Size by Region (2019-2024)
8.4 Asia-Pacific Lung Cancer Surgery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer Surgery Market Size (2019-2030)
9.2 Latin America Lung Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lung Cancer Surgery Market Size by Country (2019-2024)
9.4 Latin America Lung Cancer Surgery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Surgery Market Size (2019-2030)
10.2 Middle East & Africa Lung Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lung Cancer Surgery Market Size by Country (2019-2024)
10.4 Middle East & Africa Lung Cancer Surgery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accuray
11.1.1 Accuray Company Detail
11.1.2 Accuray Business Overview
11.1.3 Accuray Lung Cancer Surgery Introduction
11.1.4 Accuray Revenue in Lung Cancer Surgery Business (2019-2024)
11.1.5 Accuray Recent Development
11.2 Angiodynamics
11.2.1 Angiodynamics Company Detail
11.2.2 Angiodynamics Business Overview
11.2.3 Angiodynamics Lung Cancer Surgery Introduction
11.2.4 Angiodynamics Revenue in Lung Cancer Surgery Business (2019-2024)
11.2.5 Angiodynamics Recent Development
11.3 Ethicon
11.3.1 Ethicon Company Detail
11.3.2 Ethicon Business Overview
11.3.3 Ethicon Lung Cancer Surgery Introduction
11.3.4 Ethicon Revenue in Lung Cancer Surgery Business (2019-2024)
11.3.5 Ethicon Recent Development
11.4 Intuitive Surgical
11.4.1 Intuitive Surgical Company Detail
11.4.2 Intuitive Surgical Business Overview
11.4.3 Intuitive Surgical Lung Cancer Surgery Introduction
11.4.4 Intuitive Surgical Revenue in Lung Cancer Surgery Business (2019-2024)
11.4.5 Intuitive Surgical Recent Development
11.5 Olympus
11.5.1 Olympus Company Detail
11.5.2 Olympus Business Overview
11.5.3 Olympus Lung Cancer Surgery Introduction
11.5.4 Olympus Revenue in Lung Cancer Surgery Business (2019-2024)
11.5.5 Olympus Recent Development
11.6 Teleflex
11.6.1 Teleflex Company Detail
11.6.2 Teleflex Business Overview
11.6.3 Teleflex Lung Cancer Surgery Introduction
11.6.4 Teleflex Revenue in Lung Cancer Surgery Business (2019-2024)
11.6.5 Teleflex Recent Development
11.7 Ackermann Instrumente
11.7.1 Ackermann Instrumente Company Detail
11.7.2 Ackermann Instrumente Business Overview
11.7.3 Ackermann Instrumente Lung Cancer Surgery Introduction
11.7.4 Ackermann Instrumente Revenue in Lung Cancer Surgery Business (2019-2024)
11.7.5 Ackermann Instrumente Recent Development
11.8 Karl Storz
11.8.1 Karl Storz Company Detail
11.8.2 Karl Storz Business Overview
11.8.3 Karl Storz Lung Cancer Surgery Introduction
11.8.4 Karl Storz Revenue in Lung Cancer Surgery Business (2019-2024)
11.8.5 Karl Storz Recent Development
11.9 Scanlan International
11.9.1 Scanlan International Company Detail
11.9.2 Scanlan International Business Overview
11.9.3 Scanlan International Lung Cancer Surgery Introduction
11.9.4 Scanlan International Revenue in Lung Cancer Surgery Business (2019-2024)
11.9.5 Scanlan International Recent Development
11.10 Trokamed
11.10.1 Trokamed Company Detail
11.10.2 Trokamed Business Overview
11.10.3 Trokamed Lung Cancer Surgery Introduction
11.10.4 Trokamed Revenue in Lung Cancer Surgery Business (2019-2024)
11.10.5 Trokamed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’